Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanced MRI Imaging with Immune Microenvironment and Response to Atezolizumab Plus Bevacizumab Treatment.

Cancers (Basel) · 2023 · PMC10486496 · PMID 37686510

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

The difference in PFS in the cohort 2 group may not be significant, as the signal intensity in the HB phase of EOB-MRI is known to be affected by liver function.

also in 1,117 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.